Project

General

Profile

Obj. 3: Retention and VL Sup #641

3.9: Support advanced HIV disease and co-morbidities management

Added by Gilles about 1 year ago. Updated about 1 year ago.

Status:
New
Priority:
Normal
Assignee:
-
Start date:
04/01/2023
Due date:
09/30/2023 (about 12 months late)
% Done:

0%

Estimated time:
(Total: 0.00 h)
Additional Details
Rate $ Hourly
Additional Assignee

Subtasks

Obj. 3: Retention and VL Sup #844: Implement and Support screening and diagnosis of advanced HIV diseaseNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #849: Print and distribute the screening check list for opportunistic infections (OIs) during clinic or home visits New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #850: Mentor APS on screening of opportunistic infection through the screening checklistNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #851: Print and distribute the Advanced HIV Disease Registers for all 66 Sites of Center and 30 Sites of the East Print and distribute screening forms to all supported sitesNew05/01/202306/30/2023

Actions
Obj. 3: Retention and VL Sup #852: Organize cluster training of APSs on management of AHDNew05/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #853: Organize training for health care providers on management of AHDNew06/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #854: Organize a refresher sessions with all newly assigned AHD FP in all supported sites on AHD New05/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #855: Distribution of BP apparatus, scales, thermometers, and Glaucometer to 73 facilities in both regions to monitor vital parameters of clients and facilitate screening and follow up of clients with AHD New05/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #856: Financial Support implementation of WHO package of interventions for diagnosis of advanced HIV disease like CrAg, Toxoplasmosis serology, CD4; in public facilities Advocate for hospital authorities to purchase of CD4 reagents, CrAg etc New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #845: Roll out a hub and spoke system service delivery approach to support AHD key interventions New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #857: Regional training and refreshers of health care providers in supported sites on early diagnosis and management of advanced HIV disease at the regional levelNew05/01/202305/31/2023

Actions
Obj. 3: Retention and VL Sup #858: Support the transport of clients with advanced disease referrals from spokes sites to hub sites for management New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #859: Collaborate with bikers in shipping samples for advanced disease diagnosis from spokes sites to hub sitesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #860: Promote mentoring of spokes sites by hub sites to improve management of advanced diseaseNew06/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #846: Implement and Support treatment of advanced HIV disease in public hospitalsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #861: Financial support for the implementation of WHO package of interventions for treatment management of advanced HIV disease like 1) Treatment (Tuberculosis, Cryptococcosis & Toxoplasmosis) and 2) prophylaxis for major opportunistic infections (CotrimoxazoNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #862: Allocate standalone budget for facilities to manage cases of AHDNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #863: Advocate for user fee elimination for patients affected by AHD, this to enable other diagnosis and treatment for AHD to be free as TBNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #864: Implement express treatment triage programs (during consultation, and identify client with low CD4)New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #847: Train and mentor providers in advanced HIV disease and co-morbidities management for adults in new sitesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #865: Organize an onsite training of care providers in AHD for adults (Doctors and nurses) to support clinicians to strengthen skills in WHO staging and clinical presumptive diagnosis of severely ill patients to ensure adequate treatment is providedNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #866: Promote capacity building of HCP at all site providing AHD services for children, adolescents and adults for case management of AHD through mentorship, supervision, and supply chain coordinationNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #848: Ensure a proper documentation of AHD activities in the facilitiesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #867: Support printing of age-disaggregate M/E tools for AHD to allow for assessment of implementation and outcomes for childrenNew05/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #868: Continuous onsite mentorring of staff on documentation and follow up of clients diagnosed with advance HIV disease using standardized register New05/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #869: Weekly review meeting with FP on cases of AHD identified and package of services offered to clientsNew04/01/202309/30/2023

Actions

No data to display

Also available in: Atom PDF